FDA Has Approved Its First Oral Blood Thinning Medication For Children
On June 21 the U.S. Food and Drug Administration (FDA) approved Pradaxa, a blood thinner designed to treat venous thromboembolism in children between the ages of three months and 12 years old.. Dabigatran etexilate, marketed as […]
